Piper Sandler Cuts Vicarious Surgical (NYSE:RBOT) Price Target to $10.50

Vicarious Surgical (NYSE:RBOTFree Report) had its price target cut by Piper Sandler from $12.00 to $10.50 in a report issued on Wednesday,Benzinga reports. They currently have a neutral rating on the stock.

Vicarious Surgical Price Performance

Vicarious Surgical stock opened at $9.22 on Wednesday. The firm’s 50 day moving average price is $7.11 and its 200-day moving average price is $7.67. Vicarious Surgical has a 1 year low of $4.27 and a 1 year high of $21.43. The stock has a market cap of $54.37 million, a P/E ratio of -0.90 and a beta of 1.02.

About Vicarious Surgical

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

See Also

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.